What is the ticker symbol for Chinook Therapeutics?

Chinook Therapeutics trades under the ticker KDNY on NASDAQ.

What sector does Chinook Therapeutics operate in?

Chinook Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KDNY in a portfolio?

PortView shows KDNY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Chinook Therapeutics (KDNY) Stock Analysis

NASDAQHealthcareBiotechnology

$40.39+0.22%

1-year price historyRange $18.46 – $40.39

52-week range$40.39

$18.34$40.51

What Chinook Therapeutics does

Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.

Key metrics

Market cap

$2.71B

P/E (TTM)

-12.47

EPS (TTM)

$-3.24

Beta

0.67

Dividend yield

0.00%

Revenue / share

$0.10

50-day avg

$36.70

200-day avg

$26.37

52-week high

$40.51

52-week low

$18.34

CEO

Eric L. Dobmeier

ETFs linked to KDNY

Broad-market and Healthcare sector ETFs an investor holding Chinook Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KDNY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KDNY in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Chinook Therapeutics?: Chinook Therapeutics trades under the ticker KDNY on NASDAQ.
Which exchange is KDNY listed on?: KDNY is listed on NASDAQ.
What sector does Chinook Therapeutics operate in?: Chinook Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KDNY in a portfolio?: PortView shows KDNY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.